CURE LEUKAEMIA
Relief of persons suffering from leukaemia by funding new therapies, treatments and research into and trials of such treatments and providing personnel and facilities for such purposes. Enabling co-operation of scientists and clinicians to develop new and effective treatments for leukaemia. Providing resources information and support groups for leukaemia patients and their families.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net surplus of £105,278 for the year ended 31 October 2025, with total unrestricted funds carried forward amounting to £563,068. The trustees consider the present level of funding to be adequate to support the continuation of existing activities and believe no material uncertainties exist regarding going concern. The charity's reserves policy aims to maintain free reserves equivalent to between 6 and 12 months of unrestricted expenditure.
What the accounts disclose
“The charity would like to maintain unrestricted funds not committed or invested in tangible fixed assets, which are the free reserves of the charity, at a level which equates to between 6- and 12-months unrestricted expenditure.” — page 6
Structured financials (annual return, FY ending 31/10/2025)
Trustees
- Alston Owens
- DR Guy Edward Dickens Pratt
- Dr Priyanka Mehta
- Geoffrey William Cousins
- Joanne Claire Murphy
- Laura Manning Shoaf CBE
- PROFESSOR CHARLES FRANK CRADDOCK
- Philip Mark Whitehead
- Sarah Margaret Hope
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/10/2025 | £3.7m | £3.6m |
| 31/10/2024 | £2.9m | £2.9m |
| 31/10/2023 | £2.9m | £3.0m |
| 31/10/2022 | £2.7m | £2.3m |
| 31/10/2021 | £2.3m | £2.3m |
Common questions
Is CURE LEUKAEMIA financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net surplus of £105,278 for the year ended 31 October 2025, with total unrestricted funds carried forward amounting to £563,068. The trustees consider the present level of funding to be adequate to support the continuation of existing activities and believe no material uncertainties exist regarding going concern. The charity's reserves policy aims to maintain free reserves equivalent to between 6 and 12 months of unrestricted expenditure. Its FY2025 accounts were audited by JW Hinks LLP.
Who funds CURE LEUKAEMIA?
Funders whose own accounts filings name CURE LEUKAEMIA as a grant recipient include THE PENNIES FOUNDATION, THE 29TH MAY 1961 CHARITY, BNA CHARITABLE INCORPORATED ORGANISATION, THE SYNCONA FOUNDATION, THE ROAN CHARITABLE TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| THE PENNIES FOUNDATION | FY2023 | £51k | |
| THE PENNIES FOUNDATION | FY2024 | £44k | |
| THE 29TH MAY 1961 CHARITY | FY2022 | £30k | costs of a trials coordinator at their centre in Birmingham |
| BNA CHARITABLE INCORPORATED ORGANISATION | FY2023 | £25k | |
| THE SYNCONA FOUNDATION | FY2024 | £20k | |
| THE ROAN CHARITABLE TRUST | FY2022 | £10k | Relief of persons suffering from leukaemia |
| THE NOEL SWEENEY FOUNDATION | FY2023 | £5k | |
| FARRER AND CO CHARITABLE TRUST | FY2025 | £4k |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE PIERREPONT TRUST | 2 | £60k |
| THE LAWSON TRUST CIO | 2 | £21k |
| THE WILLIAM ALLEN YOUNG CHARITABLE TRUST | 2 | £5k |
| SALOMAN FOUNDATION | 1 | — |
| THE HENDRIE FOUNDATION | 1 | £199k |
| THE FIDELITY UK FOUNDATION | 1 | £94k |
| THE ALICE ELLEN COOPER-DEAN CHARITABLE FOUNDATION | 1 | £17k |
| THE GRAND CHARITY | 1 | £10k |
Charities like this
- THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
- LEUKAEMIA CARE
- THE INTERNATIONAL CML FOUNDATION
- Leukaemia UK
- SUE YOUNG CANCER SUPPORT IN LEICESTERSHIRE AND RUTLAND
- CANCER CARE AND HAEMATOLOGY FUND
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| CURE LEUKAEMIA | £3.7m | — | — | unclear | — | no doubt |
| THE CHILDREN'S CANCER AND LEUKAEMIA GROUP | £5.5m | — | — | below | — | no doubt |
| LEUKAEMIA CARE | £2.5m | — | — | above | — | no doubt |
| THE INTERNATIONAL CML FOUNDATION | £267k | £80,001 - £90,000 | 1 | unclear | 13.0% | no doubt |
| Leukaemia UK | £3.6m | £100,001 - £110,000 | 7 | within | 51.8% | no doubt |
| SUE YOUNG CANCER SUPPORT IN LEICESTERSHIRE AND RUTLAND | £225k | — | 0 | unclear | — | no doubt |